Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2023, total export contributed to 76% of total revenue from operations.
Competitive strengths Tatva Chintan Pharma Chem Company
- Leading manufacturer of structure-directing agents and phase transfer catalyst.
- Diversified product portfolio.
- Global market presence with a customer base across industries.
- Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
- Experienced promoters and managers team.
- Strong financial performance track record.
Tatva Chintan Company Financials:
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 | ||
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 | ||
| Profit After Tax | 522.62 | 377.89 | 205.43 | ||
Tatva Chintan IPO Objects of the Issue:
- Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
- Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
- To meet general corporate purposes.
Tatva Chintan Pharma IPO Details
| IPO Opening Date | Jul 16, 2023 |
| IPO Closing Date | Jul 20, 2023 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹1073 to ₹1083 per equity share |
| Market Lot | 13 Shares |
| Min Order Quantity | 13 Shares |
| Listing At | BSE, NSE |
| Issue Size | [.] Eq Shares of ₹10 (aggregating up to ₹500.00 Cr) |
| Fresh Issue | [.] Eq Shares of ₹10 (aggregating up to ₹225.00 Cr) |
| Offer for Sale | [.] Eq Shares of ₹10 (aggregating up to ₹275.00 Cr) |
Grey market premium (GMP) for Tatva Chintan Pharma has risen by 98% to Rs 1,060 ahead of its share allotment that is scheduled for July 26
Tatva Chintan IPO GMP today is ₹1060, which is ₹45 up from its yesterday’s grey market premium of ₹1015.
Tatva Chintan Pharma IPO Tentative Timetable
The Tatva Chintan Pharma IPO open date is Jul 16, 2023, and the close date is Jul 20, 2023. The issue may list on Jul 29, 2023.
| IPO Open Date | Jul 16, 2023 |
| IPO Close Date | Jul 20, 2023 |
| Basis of Allotment Date | Jul 26, 2023 |
| Initiation of Refunds | Jul 27, 2023 |
| Credit of Shares to Demat Account | Jul 28, 2023 |
| IPO Listing Date | Jul 29, 2023 |
Tatva Chintan Pharma IPO Lot Size
The Tatva Chintan Pharma IPO market lot size is 13 shares. A retail-individual investor can apply for up to 14 lots (182 shares or ₹197,106).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 13 | ₹14,079 |
| Maximum | 14 | 182 | ₹197,106 |
Tatva Chintan Pharma IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 79.17% |